Articles de revue sur le cancer colorectal - Dernières parutions

InTextoResearch, agence d'information scientifique


InTextoResearch vous informe sur les dernières parutions d'articles de
revue sur le cancer colorectal (3 novembre 2007):


DNA methylation markers: a versatile diagnostic tool for routine
clinical use.
Lesche R, Eckhardt F.
Curr Opin Mol Ther. 2007 Jun;9(3):222-30.

Cost considerations in the treatment of colorectal cancer.
Jansman FG, Postma MJ, Brouwers JR.
Pharmacoeconomics. 2007;25(7):537-62.

Cyclooxygenase-2 as target for chemopreventive interventions: new
approaches.
Dvory-Sobol H, Arber N.
Cancer Biomark. 2007;3(3):153-61.

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal
cancer.
O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM.
Lancet Oncol. 2007 Jul;8(7):625-33.

The future of the TNM staging system in colorectal cancer: time for a
debate?
Quirke P, Williams GT, Ectors N, Ensari A, Piard F, Nagtegaal I.
Lancet Oncol. 2007 Jul;8(7):651-7.

EGFR targeting of solid tumors.
Rocha-Lima CM, Soares HP, Raez LE, Singal R.
Cancer Control. 2007 Jul;14(3):295-304.

Panitumumab in colorectal cancer.
Wainberg ZA, Hecht JR.
Expert Rev Anticancer Ther. 2007 Jul;7(7):967-73.

New approaches in systemic treatment of advanced colorectal cancer:
the molecular targets era.
Capdevila J, Mendez G, Macarulla T, Ramos FJ, Casado E, Tabernero J.
Expert Rev Anticancer Ther. 2007 Jul;7(7):1027-41.

Technology insight: confocal laser endoscopy for in vivo diagnosis of
colorectal cancer.
Kiesslich R, Goetz M, Vieth M, Galle PR, Neurath MF.
Nat Clin Pract Oncol. 2007 Aug;4(8):480-90.

Colorectal cancer: what has changed in diagnosis and treatment over
the last 50 years?
Gennari L, Russo A, Rossetti C.
Tumori. 2007 May-Jun;93(3):235-41.

The paracrine hormone hypothesis of colorectal cancer.
Pitari GM, Li P, Lin JE, Zuzga D, Gibbons AV, Snook AE, Schulz S,
Waldman SA.
Clin Pharmacol Ther. 2007 Oct;82(4):441-7.

Current and future clinical strategies in colon cancer prevention and
the emerging role of chemoprevention.
Boursi B, Arber N.
Curr Pharm Des. 2007;13(22):2274-82.

End points in advanced colon cancer clinical trials: a review and
proposal.
Allegra C, Blanke C, Buyse M, Goldberg R, Grothey A, Meropol NJ, Saltz
L, Venook A, Yothers G, Sargent D.
J Clin Oncol. 2007 Aug 20;25(24):3572-5.

Clinical use of monoclonal antibodies to the epidermal growth factor
receptor in colorectal cancer.
Burtness B.
Oncology (Williston Park). 2007 Jul;21(8):964-70

Primer: Applying the new postpolypectomy surveillance guidelines in
clinical practice.
Kahi CJ, Rex DK.
Nat Clin Pract Gastroenterol Hepatol. 2007 Oct;4(10):571-8.

Colorectal cancer.
Ballinger AB, Anggiansah C.
BMJ. 2007 Oct 6;335(7622):715-8.

The role of integrins in colorectal cancer.
Le Tourneau C, Faivre S, Raymond E.
Oncology (Williston Park). 2007 Aug;21(9 Suppl 3):21-4.


(contact pour InTextoResearch: Marc Lacroix, Baelen, Wallonie,
Belgique - scimedweb@mail.com)